🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
The purpose of this study is to test the safety of a new medication, Olapar...
Status
Completed
Location
Baptist Alliance Miami Cancer Institute
Start Date
2018-07-12
Trial ID
NCT03532880
This is a 2-part study in patients with advanced solid tumours. Part A will...
Status
Completed
Location
Research Site
Start Date
2013-11
Trial ID
NCT01894256
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of pembroliz...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-11-17
Trial ID
NCT02861573
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested
This is a 2-part study in patients with advanced solid tumours. Part A will...
Status
Completed
Location
Research Site
Start Date
2013-12
Trial ID
NCT01929603
Treatments Being Tested
A study to find out whether olaparib is safe and well tolerated when admini...
Status
Completed
Location
Research Site
Start Date
2020-01-14
Trial ID
NCT04236414
Treatments Being Tested
This is a 2-part study in patients with advanced solid tumours. Part A will...
Status
Completed
Location
Research Site
Start Date
2014-03-13
Trial ID
NCT01894243
Treatments Being Tested
Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2014-04-07
Trial ID
NCT02299999